Tabletted guar gum microspheres of piroxicam for targeted adjuvant therapy for colonic adenocarcinomas

Therapeutic Delivery

Volumn 3, Issue 11, 2012, Pages 1281-1295

  Vats, Anima ^a   Pathak, Kamla ^a  

^a Rajiv Academy for Pharmacy   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EUDRAGIT; GUAR GUM; GUAR GUM MICROSPHERE; MICROSPHERE; PIROXICAM; UNCLASSIFIED DRUG;

ABDOMINAL RADIOGRAPHY; ANIMAL EXPERIMENT; ARTICLE; CANCER ADJUVANT THERAPY; COLON ADENOCARCINOMA; CONTROLLED STUDY; CROSS LINKING; DRUG COATING; DRUG DISTRIBUTION; DRUG RELEASE; DRUG SAFETY; DRUG TARGETING; INTESTINE FLUID; INTESTINE TRANSIT TIME; MATRIX TABLET; NONHUMAN; PRIORITY JOURNAL; PROCESS OPTIMIZATION; SIMULATION; STOMACH JUICE; TABLET COMPRESSION; TABLET FORMULATION; TABLET MATRIX; TIMED DRUG RELEASE; TISSUE DISTRIBUTION;

EID: 84870203839     PISSN: 20415990     EISSN: 20416008     Source Type: Journal    
DOI: 10.4155/tde.12.116     Document Type: Article

References (42)

1. Giardiello FM, Offerhaus GJA, Dubois RN. The role of nonsteroidal anti-infammatory drugs in colorectal cancer prevention. Eur. J. Cancer 31A(718), 1071-1076 (1995).
2. Chaurasia M, Chourasia MK, Jain NK et al. Cross-linked guar gum microspheres: A viable approach for improved delivery of anticancer drugs for the treatment of colorectal cancer. AAPS Pharm. Sci. Tech. 7(3), E1-E9 (2006).
3. Calaluce R, Earnest DL, Heddens D et al. Effects of piroxicam on prostaglandin E2 levels in rectal mucosa of adenomatous polyp patients: A randomized phase IIb trial. Cancer Epidemiol. Biomarkers Prev. 9(12), 1287-1292 (2000). (Pubitemid 32044796)
4. Banerjee R, Chakraborty H, Sarkar M. Photophysical studies of oxicam group of NSAIDs: piroxicam, meloxicam and tenoxicam. Spectrochimica Acta 59(6), 1213-1222 (2003).
5. Srivastava R, Kumar D, Pathak K. Colonic luminal surface retention of meloxicam microsponges delivered by erosion based colon-targeted matrix tablet. Int. J. Pharm. 427, 153-162 (2012).
6. Okajima E, Ozono S, Endo T et al. Chemopreventive effcacy of piroxicam administered alone or in combination with lycopene and b-carotene on the development of rat urinary bladder carcinoma after N-butyl-N-(4 hydroxybutyl) nitrosamine treatment. J. Cancer Res. 88, 543-552 (1997). (Pubitemid 27348490)
7. Noguchi M, Earashi M, Minami M, Miyazaki I, Tanaka M, Sasaki T. Effects of piroxicam and esculetin on the MDA-MB-231 human breast cancer cell line. Prostaglandins Leukot. Essent. Fatty Acids 53(5), 325-329 (1995).
8. Li H, Kramer PM, Lubet RA, Steele VE, Kelloff GJ, Pereira MA. Termination of piroxicam treatment and the occurrence of azoxymethane-induced colon cancer in rats. Cancer Lett. 147, 187-193 (1999).
9. Earnet DL, Hixson LJ, Alberts DS et al. Piroxicam and other cyclooxygenase inhibitors: potential for cancer chemoprevention. J. Cellular Biochem. 50 (16), 156-166 (2004).
10. Schmidt BR, Glickman NW, DeNicola DB, de Gortari AE, Knapp DW. Evaluation of piroxicam for the treatment of oral squamous cell carcinoma in dogs. J. Am. Vet. Med. Assoc. 218(11) 1783-1786 (2001). (Pubitemid 32520131)
11. Ross DS, Bitzer D, Roy T, Murphy JE. Piroxicam inhibits the growth of an adenocarcinoma isograft in Fischer rats. J. Surg. Res. 45(3), 249-253 (1988).
12. Pollard M, Luckert PH, Schmidt MA. The suppressive effect of piroxicam on autochthonous intestinal tumors in the rat. Cancer Lett. 21(1), 57-61 (1983). (Pubitemid 14203083)
13. Pollard M, Luckert PH. Effect of piroxicam on primary intestinal tumors induced in rats by N-methylnitrosourea. Cancer Lett. 25(2), 117-121 (1984). (Pubitemid 15195072)
14. Reddy BS, Maruyama H, Kelloff G. Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal antiinfammatory drug, during different stages of rat colon tumor development. Cancer Res. 47, 5340-5346 (1987). (Pubitemid 17152943)
15. Solanki AB, Parikh JR, Parikh RH. Formulation and optimization of piroxicam proniosomes by 3-factor, 3-level box-behnken design. AAPS Pharm. Sci. Tech. 8(4) E86 (2007).
16. Ahmad MZ, Akhter S, Ahmad I et al. Development of polysaccharide based colon targeted drug delivery system: design and evaluation of Assam Bora rice starch based matrix tablet. Curr. Drug Deliv. 8(5), 575-581 (2011).
17. Abdel-Halima ES, Al-Deyab, Salem S. Hydrogel from crosslinked polyacrylamide/guar gum graft copolymer for sorption of hexavalent chromium ion. Carbohydrate Polym. 86, 1306-1312 (2011).
18. Patel MM, Amin AF. Process, optimization and characterization of mebeverine hydrochloride loaded guar gum microspheres for irritable bowel syndrome. Carbohydrate Polym. 86, 536-545 (2011).
19. Ji CM, Xu HN, Wu W. Guar gum as potential flm coating material for colon-specifc delivery of fuorouracil. J. Biomaterials Applications 23, 311-329 (2009).
20. Prasad Y V, Krishnaiah YSR, Satyanarayana S. In vitro evaluation of guar gum as a carrier for colon-specifc drug delivery. J. Control. Release 51, 281-287 (1998). (Pubitemid 28252880)
21. Wong TW, Chan LW, Lee HY, Heng PW. Release characteristics of pectin microspheres prepared by an emulsifcation technique. J. Microencapsul. 19, 511-522 (2002).
22. Martin A, Bustamante P, Chun A. Micromeritics in physical pharmacy: physical chemical principles. In: The Pharmaceutical Science (4th edition). Lippincott Williams and Wilkins. Philadelphia, PA, USA, 446-448 (2002).
23. Dev RK, Bali V, Pathak K. Novel microbially triggered colon specifc delivery system of 5-fuorouracil: statistical optimization, in vitro, in vivo, cytotoxic and stability assessment. Int. J. Pharm. 411, 142-151 (2011).
24. Mazumder B, Bhattacharya S, Mohanta B, Dey S, Maity A. Preparation and in vitro evaluation of chlorpheniramine maleate loaded microspheres. Int. J. Pharm. Tech. Res. 1(3), 905-913 (2009).
25. Jain SK, Rai G, Saraf DK. The preparation and evaluation of albendazole microspheres for colonic delivery. Pharm. Tech. 66-71 (2004). (Pubitemid 39627755)
26. Wu J, Wei L, Wang Y, Su Z, Ma G. Preparation of uniform-sized pH-sensitive quaternized chitosan microsphere by combining membrane emulsifcation technique and thermal-gelation method. Colloids Surf. B Biointerfaces 63, 164-175 (2008).
27. Sahoo SK, Mallick AA, Barik BB, Senapati PC. Formulation and in vitro evaluation of Eudragit microspheres of stavudine. Trop. J. Pharm. Res. 4, 369-375 (2005).
28. Islami N, Moghadam SH, Atyabi F, Dinarvand R. Preparation and characterization of estradiol valerate microspheres using biodegradable polymers. Iran. J. Pharm. Sci. 2(1), 3-10 (2006).
29. Vyas SP, Khar RK. Targeted and Controlled Drug Delivery (1st Edition). CBS Publisher and Distributor, New Delhi, India, 417-457 (2004).
30. Rowe RC, Sheskey PJ, Owen SC. Handbook of Pharmaceutical Excipient (5th Edition). Pharmaceutical Press, London, UK, 507-508 (2006).
31. Khare P, Jain SK. Infuence of rheology of dispersion media in the preparation of polymeric microspheres through emulsifcation method. AAPS Pharm. Sci. Te c h. 10(4), 1295-1300 (2009).
32. Wang LY, Ma GH, Su ZG. Preparation of uniform sized microspheres by membrane emulsifcation technique and application as a carrier of protein drug. J. Control. Release 106(1-2), 62-75 (2005).
33. Rahman Z, Kohli K, Khar RK, Ali M, Charoo NM, Shamsher AAA. Characterization of 5-fuorouracil microspheres for colonic delivery. AAPS Pharm. Sci. Tech. 7(2) E113-E121 (2006).
34. Babu VR, Sairam M, Hosamani KM, Aminabhvi TM. Preparation of sodium alginate-methylcellulose blend microspheres for controlled release of nifedipine. Carbohydrate Polym. 69, 241-250 (2007). (Pubitemid 46617746)
35. Chiao CSL, Price JC. Formulation, preparation and dissolution characteristics of propranolol hydrochloride microspheres. J. Microencapsul. 11, 153-159 (1994). (Pubitemid 24090042)
36. Yadav AV, Mote HH. Development of biodegradable starch microspheres for intranasal delivery. Ind. J. Pharm. Sci. 70(2), 170-174 (2008).
37. Janik M, Malarski Z, Mrozinski J, Wajcht J, Zborucki Z. Infuence of solvent effect on polymorphism of 4-hydroxy-2-methyl-N-2-pyridyl-2H-1, 2-benzothiazine-3-carboxam ide-1, 1-dioxide (piroxicam). J. Crystallogr. Spec. Res. 21, 519-522 (1991).
38. Mudgil D, Barak S, Khatkar BS. x-ray diffraction, IR spectroscopy and thermal characterization of partially hydrolyzed guar gum. Int. J. Bio. Macromol. 50, 1035-1039 (2012).
39. Lamprecht A, Yamamoto H, Takeuchi H, Kawashima Y. Design of pH sensitive microspheres for the colonic delivery of the immunosuppressive drug tacrolimus. Eur. J. Pharm. Biopharm. 58, 37-43 (2004). (Pubitemid 38781002)
40. Jelvehgari M, Nokhodchi A, Rezapour M, Valizadeh H. Effect of formulation and processing variables on the characteristics of tolmetin microspheres prepared by double emulsion solvent diffusion method. Ind. J. Pharm. Sci. 72(1), 72-78 (2010).
41. Jain S, Yadav SK, Patil UK. Preparation and evaluation of sustained release matrix tablet of furosemide using natural polymers. Res. J. Pharm. Tech. 1(4), 374-376 (2008).
42. Shobha MS, Vishu Kumar AB, Tharanathan RN, Koka R, Gaonkar AK. Modifcation of guar galactomannan with the aid of Aspergillus niger pectinase. Carbohydrate Polym. 62(3), 267-273 (2005). (Pubitemid 41737571)